TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 36 | 33 | −3 |
| Shares | 7.00M | 6.42M | −584.5K (−8.3%) |
| Value | $4.80M | $3.02M | −$1.78M (−37.1%) |
New holders (3)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ORG Partners LLC | 18,500 | $8.88K | 0.00% |
| Group One Trading, L.P. | 1,768 | $831 | 0.00% |
| Royal Bank of Canada | 137 | $0 | 0.00% |
Sold out (6)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 23,800 | $16.3K |
| Susquehanna International Group, LLP | 14,253 | $9.77K |
| Two Sigma Investments, LP | 11,008 | $7.54K |
| Venturi Wealth Management, LLC | 10,134 | $6.95K |
| Baldwin Brothers Inc | 10,000 | $6.85K |
| Citadel Advisors LLC | 1,540 | $1.05K |